Zobrazeno 1 - 10
of 177
pro vyhledávání: '"Jarmo A. Salo"'
Publikováno v:
Cancer Treatment and Research Communications, Vol 27, Iss , Pp 100362- (2021)
Background: Robotic assistance in lung lobectomy has been suggested to enhance the adoption of minimally invasive techniques among surgeons. However, little is known of learning curves in different minimally invasive techniques. We studied learning c
Externí odkaz:
https://doaj.org/article/0d71195aa3594a678a9dd74be29802b3
Autor:
Jari Räsänen, Sanna Laaksonen, Eeva Kettunen, Tapio Vehmas, Marjukka Myllärniemi, Juuso Paajanen, Jarmo A. Salo, Eva Sutinen, Ilkka Ilonen, Henrik Wolff, Mikko I. Mäyränpää
Publikováno v:
Clinical Lung Cancer. 21:e633-e639
Within a larger national malignant pleural mesothelioma cohort, we identified 43 patients with unusually long survival times. This study aimed to evaluate the diagnostic accuracy in this subgroup, and the diagnosis was confirmed to be correct in most
Autor:
Eva Sutinen, Henrik Wolff, Jari Räsänen, Tapio Vehmas, Katri Koli, Eeva Kuosma, Sanna Laaksonen, Jarmo A. Salo, Kirsti Husgafvel-Pursiainen, Ilkka Ilonen, Marjukka Myllärniemi
Publikováno v:
Acta Oncologica. 58:38-44
Background: Malignant pleural mesothelioma (MPM) is a rare occupational cancer with a poor prognosis. Even with a multimodality treatment approach, the treatment outcomes remain unsatisfactory. The use of asbestos has been banned in most developed co
Publikováno v:
Clinical Lung Cancer. 19:418-425
The role of positive lymph node location in non-small-cell lung cancer (NSCLC) patients and effects on survival was assessed. A total of 88 operated patients with unsuspected N2 disease or station 10 lymph nodes were included. No difference was found
Autor:
Jarmo A. Salo, Eeva Kettunen, Mikko I. Mäyränpää, Ilkka Ilonen, Jari Räsänen, Tapio Vehmas, Henrik Wolff, Hely Ollila, Eva Sutinen, Marjukka Myllärniemi, Juuso Paajanen, Sanna Laaksonen
Publikováno v:
Human pathology. 98
Diffuse malignant mesothelioma (DMM) of the pleura is a rare and aggressive disease, where the long-term survival (LTS) rate is low. The epithelioid subtype is the most prevalent form of DMM with the best prognosis. In order to study prognostic histo
Publikováno v:
Thoracic Cancer. 9:1429-1436
Background In esophageal cancer, nutritional challenges are extremely common. Malignant obstruction resulting from esophageal cancer (EC) is often treated by the insertion of expandable stents, but little is known as to the role and evolution of sarc
Publikováno v:
Journal of Thoracic Disease. 9:E698-E701
Oesophageal hamartomas are extremely rare conditions especially in upper oesophagus. We report on a 20-year-old woman who presented with dysphagia and was diagnosed with a retrosternal 4.9 cm × 9.0 cm heterogenic tumour located in her upper oesophag
Autor:
Robert J. Cerfolio, Carolyn Apperson-Hansen, M. Pera, Toni Lerut, Chen Lq, André Duranceau, James D. Luketich, Jarmo A. Salo, Chadrick E. Denlinger, Eugene H. Blackstone, Simon Law, Hemant Ishwaran, Thomas J. Watson, Paul H. Schipper, Walter J. Scott, Gail Darling, Wayne L. Hofstetter, Thomas W. Rice, Mark S. Allen, Valerie W. Rusch, Kenneth A. Kesler
Publikováno v:
Annals of Surgery. 265:122-129
OBJECTIVES: To identify the associations of lymph node metastases (pN+), number of positive nodes, and pN subclassification with cancer, treatment, patient, geographic, and institutional variables, and to recommend extent of lymphadenectomy needed to
Autor:
Jari Räsänen, Pauliina Reijonen, Jari Rantonen, Antti Kivelä, Anne Juuti, Helena Isoniemi, Jarmo A. Salo, Arno Nordin
Publikováno v:
Surgical oncology. 30
Background and aims Previously, colorectal cancer (CRC) metastasis of both liver and lungs was considered disseminated disease, which contraindicated surgical metastasectomies. Increasing evidence from studies on patient series have indicated that su
Autor:
Sanna Laaksonen, Silja A.S. Salo, Ilkka Ilonen, Jarmo A. Salo, Tuomo Rantanen, Marjukka Myllärniemi
Publikováno v:
Anticancer research. 39(2)
Background Malignant peritoneal mesothelioma (MPeM) is a rare type of cancer with a poor prognosis. Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) have been shown to improve survival. Treatment and survival of pati